Clinical Trial Update: Haploidentical NK-cell Infusion in Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of haploidentical NK-cell infusion in Acute Myeloid Leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Haploidentical NK cell infusion

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED